Aug 27, 2026 05:47PM
Aug 27, 2026 05:47PM
Aug 24, 2026 06:31AM
Aug 24, 2026 06:31AM
Aug 4, 2026 04:01PM
Aug 4, 2026 04:01PM
Jul 24, 2026 06:26AM EU panel backs Gilead's Trodelvy plus Keytruda for breast cancer
Jul 24, 2026 06:26AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jul 21, 2026 10:00AM
Jun 24, 2026 04:29PM
Jun 24, 2026 04:29PM U.S. FDA Approves Trodelvy® for First-Line Treatment of Metastatic Triple-Negative Breast Cancer
Jun 24, 2026 08:30AM
Jun 23, 2026 07:45AM
Jun 23, 2026 07:45AM
Jun 16, 2026 07:05AM
Jun 15, 2026 04:34PM
Jun 15, 2026 04:34PM
Jun 8, 2026 04:35PM Gilead and Merck announce successful HIV treatment trial results
Jun 8, 2026 04:35PM
Jun 8, 2026 04:30PM
Jun 8, 2026 04:30PM
Jun 4, 2026 04:15PM
Jun 4, 2026 04:15PM
Jun 2, 2026 08:30AM
Jun 2, 2026 08:30AM Gilead’s Livdelzi® (Seladelpar) Delivers Statistically Significant Composite ALP Normalization in Phase 3 IDEAL Trial in Primary Biliary Cholangitis (PBC)
May 27, 2026 02:00AM
May 27, 2026 02:00AM
May 22, 2026 02:00PM
May 22, 2026 02:00PM
May 22, 2026 01:42PM
May 22, 2026 07:47AM
May 22, 2026 07:47AM Gilead Receives CHMP Positive Opinion for Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer for Patients Not Candidates for PD-(L)1 Inhibitors
May 21, 2026 05:00PM
May 13, 2026 08:30AM
May 13, 2026 08:30AM
May 7, 2026 04:01PM
Apr 29, 2026 08:30AM
Apr 29, 2026 08:30AM
Apr 28, 2026 08:45AM Gilead Sciences completes $7.8 billion Arcellx acquisition
Apr 28, 2026 08:45AM
Apr 14, 2026 12:03PM
Apr 14, 2026 12:00PM
Mar 31, 2026 06:19AM
Mar 24, 2026 06:36AM
Mar 23, 2026 06:15PM
Mar 23, 2026 06:15PM Gilead Sciences to Acquire Ouro Medicines to Advance First in Class T Cell Engager Program for Autoimmune Diseases
Feb 25, 2026 01:50PM

330,341 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All